Although necrostatin-1 treatment showed organ-protective effects in various IR injury models except the liver [6, 7, 10, 15], our data demonstrated that nec-1 (data not shown) and nec-1s (stable long acting nec-1) did not exhibit protective effects on the hepatic IR injury model. This evidence concerns the gene PCSK1 and hepatitis A virus infection.